NCT02668536View on ClinicalTrials.gov

A Sunscreen Based on Bioadhesive Nanoparticles

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

August 18, 2017

Study Completion Date

August 18, 2017

Conditions
MelanomaUV Ray Skin Damage
Interventions
DRUG

Standard Sunscreen

Areas will be treated with a standard preparation, consisting of padimate O (7%) and oxybenzone (3%) will be used as the control sunscreen.

DEVICE

BNP

Additional areas will be treated with empty bioadhesive nanoparticles (BNPs).

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02668536 - A Sunscreen Based on Bioadhesive Nanoparticles | Biotech Hunter | Biotech Hunter